Temperature changes among organophosphate poisoned patients, Tehran- Iran by Haleh Talaie et al.
Talaie et al. DARU Journal of Pharmaceutical Sciences 2012, 20:52
http://www.darujps.com/content/20/1/52RESEARCH ARTICLE Open AccessTemperature changes among organophosphate
poisoned patients, Tehran- Iran
Haleh Talaie1,2, Hamid Owliaey2, Abdolkarim Pajoumand1,2, Mona Gholaminejad1 and Omid Mehrpour3,4*Abstract
Background: Acute poisoning with organophosphorus compounds (OPs) is a major global clinical problem in the
developing countries. There have been many animal studies and few human surveys on the effects of
organophosphorus pesticide (OP) poisoning on thermoregulation. The aim of this prospective study was to
document the pattern of tympanic temperature changes among OP poisoned patients throughout the length of
their hospital stay.
Methods: 60 patients with diagnose of organophosphate poisoning were included in this study. Questioner was
filled out by trained nurses including demographic, clinical and paraclinical data. Tympanic temperature and Pulse
rate data of the cases were collected on five- occasions after admission.
Results: There were 41 (68.3%) male and 19 (31.7%) female, with a mean age of 34.4 ±19.4 years (range
13–89 years). Forty five patients had intentional poisoning for suicidal attempt. At the time of entry, the mean
tympanic temperature, pulse rate, respiratory rate and blood pressure (systolic and diastolic) of the OP poisoned
patients were respectively 37.1+/−0.6°C (36.0- 39.5), 91+/−18 (55–145), 18+/−5.6 (8–44), 116+/−20 mm Hg (70–170)
and 75+/−11.6 mm Hg (40–110). 41.7% of the cases had serum butyryl cholinesterase activities (BChE) ≥ 50%
normal (≥1600 mU/ml). Our patients had normal temperature at the time entry (mean = 37.1). Tympanic
temperature decreasing below 36°C was not detected among the patients during the study period. A rise in mean
tympanic temperature was found after atropine administration.
Conclusion: Our study showed hypothermia was not considerable factor among organophosphate poisoned
patients, although more studies with similar situations in tropical countries are needed.
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Acute poisoning with organophosphorus compounds
(OPs) is a major global clinical problem in the develop-
ing countries with a significant cause of morbidity and
mortality. It can occur in a variety of situations such as
agricultural use, accidental exposure, suicide and, rarely,
homicide [1,2]. Organophosphorus compounds form a
large family of ~50 000 chemical agents [3].
These compounds act by inhibiting acetylcholinester-
ase activity at muscarinic and nicotinic receptors in the* Correspondence: omid.mehrpour@yahoo.com.au
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reproduction in any medium, provided the orbrain and different parts of neuromuscular junctions.
Four clinical syndromes that have been described in
patients with OPs poisoning, are cholinergic crisis, inter-
mediate syndrome, delayed neuropathy and chronic
organophosphate inducted neuropsychiatric disorder.
Whichever stages has special signs and symptoms [4].
The conventional and standard treatment involves
supportive care, detoxification and administration of
intravenous atropine sulfate, a central and peripheral
muscarinic receptor antagonist, and pralidoxime chlor-
ide to counter acetyl cholinesterase inhibition at the
synapse [4-6].
However, the pathophysiology of OPs poisoning is not
completely known, reports indicate that OPs interfere
with the control of acetylcholine-regulated homeostatic
mechanisms such as temperature regulation. Studies ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Distribution of age and sex among patients
Age 1-10y 11-20y 21-30y 31-40y 41-50y 51-60y 61-70y 71-80y 81-90y Total
Sex N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Male - 4 (9.8) 18 (43.9) 4 (9.8) 5 (12.2) 4 (9.8) 2 (4.9) 2 (4.9) 2 (4.9) 41 (100)
Female 1 (5.3) 6 (31.6) 9 (47.4) 1 (5.3) 1 (5.3) - - 1 (5.3) - 19 (100)
Total 1 (1.7) 10 (16.7) 27 (45) 5 (8.3) 6 (10) 4 (6.7) 2 (3.3) 3 (5) 2 (3.3) 60 (100)
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ect CNS administration of cholinergic agonists in the re-
gion of their hypothalamus or cerebral ventricles, on the
contrary other survey found heat production. It is sug-
gested that temperature's variables may be dose
dependent, for example, generally higher doses were
associated with hypothermia, and hyperthermia was only
seen with lower doses [6,7].
Other studies indicated that a period of hypothermia
followed by a fever of delayed onset in OP poisoning,
without existence of viral or bacterial infection [8-11].
According to several studies on human OP poisoning,
elevation in body temperature was a frequent outcome,
but cases were complicated by concurrent illnesses (in
particular aspiration pneumonitis/pneumonia) and inter-
ventions that may of themselves produce high tempera-
tures, in particular anticholinergic agents [6,12]. The
aim of this study was to obtain the pattern of tympanic
temperature changes among OP poisoned patients
throughout the length of their hospital stay.
Methods
This prospective chart review study was conducted on
patients with OP poisoned suspicious that admitted to
our 18- bed Toxicological Intensive Care Unit (TICU)
and 45- bed poison ward of Loghman Hakim Hospital
Poison Center (LHHPC), from October 2010 to Septem-
ber 2011. This hospital is a unique care teaching and re-
ferral poison treatment center in Tehran with nearly an
annual average of 20000 hospital visits [13]. The study
protocol with code number 101 was reviewed and
approved by ethics review committee in Research Dep-
uty Department of the Shahid Beheshti University of
Medical Sciences, Tehran, Iran. During the period of
study, sixty cases with diagnosis of OP poisoning
included. The diagnose was confirmed by based on in-
formation taken either from the patient or from the
Patient’s family about the OP exposure, the odor of OPs
in the gastric contents and cholinergic clinical features
and measuring butyrylcholinesterase activities (BChE) inTable 2 Time interval between exposure and hospital arrival
Time to admission (h) unknown <1 (h)
N (%) N (%)
Organophosphorus 7 (11.7) 13 (21.7)the first 24 hours. The serum BChE categorized in 3
groups which included: ≤20% normal, between 20 to
50% and ≥50% normal. Standard treatment was used for
patients: gastric lavage, whole body surface washing,
activated charcoal administration (1 g/kg by nasogastric
tube), intravenous atropine and pralidoxime in OP poi-
soned patients, and supportive measures such as mech-
anical ventilation (if necessary). Questioner was filled
out by trained nurses including demographic, clinical
and paraclinical data. The patients' demographic infor-
mation (sex, age), vital signs at the entrance, co ingestion
with other drugs or substances, clinical manifestation
(muscarinic and nicotinic symptoms), CNS status, intub-
ation, acetyl cholinesterase levels, dose of atropine and
paralidoxims (bolus administration, infusion) and the
length of administrate of these drugs were extracted by
review of medical records. The Glasgow Coma Scale
(GCS) of patients were determined. Tympanic
temperature and Pulse rate data of the cases were col-
lected in five- occasions. There were included: at entry
time, after atropine treatment, after 24 hrs, after 72 hrs
and at the discharge. More data such as aspiration pneu-
monia complication, opioid's withdrawal syndrome and
other drugs' medication mentioned. The statistical ana-
lysis was performed with Statistical Product and Service
Solutions (SPSS) version 16 (SPSS Inc., Chicago, IL,
USA). Data of the participants were analyzed through
appropriate statistical testes, such as Chi-square test (χ2)
for categorical and Student's t-test. P-values equal to or
less than 0.05 considered significant.
Results
Over the 1- year, 60 poisoned cases with OP poisoning
were registered in Loghman Hakim Hospital, with a
mean age of 34.4 ±19.4 years (Range: 2–89 years). There
were 41 (68.3%) male and 19 (31.7%) female.
Table 1 showed distribution of age and sex among
patients. Forty five patients (75%) had intentional poi-
soning for suicidal attempt and 15 cases (25%) had acci-
dental exposure. Four patients had positive history of co(h)
1-6(h) 7-24(h) >24(h) Total
N (%) N (%) N (%) N (%)
33 (55.1) 3 (5.1) 4 (6.7) 60 (100)
Table 4 OP poisoned patients' serum

















Number (%) 19 (31.7) 16 (26.7) 25 (41.7) 60 (100)
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ethanol (n = 2) and benzodiazepine (n = 2).
Most of the patients (n = 46) arrived to the hospital
during the first 6 hours of ingestion (Table 2).
GCS of 56 patients during the first 24 hours were
above 10 and 4 case had GCS between 3–6. At the time
of entry, the mean tympanic temperature, pulse rate,
respiratory rate and blood pressure (systolic and dia-
stolic) of the OP poisoned patients were respectively
37.1+/−0.6°C (36.0- 39.5), 91+/−18 (55–145), 18+/−5.6
(8–44), 116+/−20 mm Hg (70–170) and 75+/−11.6 mm
Hg (40–110). The most frequent clinical signs and
symptoms were miosis and hyper salivation followed by
vomiting (Table 3).
41.7% of the cases had serum butyryl cholinesterase
activities (BChE) ≥ 50% normal (≥1600 mU/ml). Patients'
serum butyrylcholinesterase activities (BChE) in the first
24 hours were shown in Table 4.
The average bolus atropine dose in OP poisoned
patients' records was 7.4 ± 16.9 mg and the highest dose
was 100 mg just in one case. Atropine was given during
5.5 ± 3.6 days (range 4 hours - 15 days) and the average
infusion atropine dose was 110.2 ± 90.7 mg.
A total of 31 (51.7%) patients received pralidoxime. The
mean bolus paralidoxime dose was1.4 ± 0.6 g. Pralidoxime
was administered for 6.3 ± 5 days (Range: 2 hours -18 days)
and the mean dose was 41.6 ± 30 g.
As other medication that we used, benzodiazepines
(Diazepam–Midazolam) were the most frequent
(Table 5).
Figure 1 showed the mean tympanic temperature
changes among patients throughout the length of their
hospital stay. Figure 2 showed the mean pulse rate
changes among patients throughout the length of their
hospital stay. Hypothermia was not detected among the
patients even at the time entry. A rise in mean tympanic










Hyper salivation 22 (36.7) Fasciculation 3 (5)
Tearing 15 (25)
Miosis 22 (36.7)






(Rales , wheeze, Ronchy)
22 (36.5)Intubation and consequent mechanical ventilatory
support was needed for 30 (50%) patients. It is notable
that14of these mechanically ventilated patients were
complicated by aspiration pneumonia (AP). Out of 14
patients with AP, 4 cases died. Seizure occurred in 6
patients. Drugs withdrawal was reported in 2 cases. Ten
of the 60 patients died and mortality rate was 16.6%.
Discussion
In this study we found that patients had mean tympanic
temperature 37.1°C at the time entry and a rise in mean
tympanic temperature after atropine administration.
OPs have been reported to interfere with temperature
regulation [7]. Most of surveys about effect of organo-
phosphate on temperature regulation are from animal
studies. Direct CNS administration of cholinergic ago-
nists in the hypothalamus or cerebral ventricles of
rodents induced hypothermia, but other studies report-
ing heat production and fever [6,7]. This different may
be related to dose of organophosphate; in general, higher
doses of OPs were associated with hypothermia, and
hyperthermia was seen with lower doses of OPs [6].
Other studies have been proved that without other clas-
sical signs of bacterial or viral infection, OP poisoning
induced a period of hypothermia followed by a delayed
onset of fever [8,9]. Moreover, hot and cold environ-
ments may changes sensitivity of rats to AChE inhibitors
and also hypothermic and hyperthermic effects in animal
models [6].
Very few study have evaluated effect of OP poisoning
on temperature regulation, Moffatt A et al. in a pro-
spective case series study found that OP poisoning
causes an initial fall in body temperature, and this is fol-
lowed by a period of normal to high body temperature,Table 5 Other medications that were used among the OP
poisoned patients
Other Medications Patients Number (%)
NAC* 8 (13.33)
Sodium bicarbonate 14 (23.33)
Benzodiazepines Diazepam Midazolam 15 (25)
19 (31.66)
Magnesium sulphate 12 (20)
NAC: N acetyl cysteine.
Figure 1 Mean tympanic temperature changes among patients throughout the length of their hospital stay.
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similar to our study, although most of our cases had nor-
mal temperature at time of admission, it was important
to know that in Moffatt et al. study, hypothermia may be
related to co ingestion of alcohol in some patients.
Numerous animal surveys noted purely hypothermic
or hyperthermic responses to OP poisoning and they
suggested that there was a significant correlation be-
tween OP exposure and hypersensitivity to ambient tem-
peratures [6,12,14,15]. On the other hand, we detected
hyperthermia among the patients after atropinization.
Some studies noted that elevation in body temper-
ature was a frequent outcome, but cases were compli-
cated by concurrent illnesses (in particular aspirationFigure 2 Mean pulse rate changes among patients throughout the lepneumonitis/pneumonia) and interventions that may of
themeselves produce high temperatures, in particular
anticholinergic agents. They noted that it is unknown
whether atropine was responsible for the temperature
or whether high doses of atropine were given to
patients with severe OP poisoning, and fever was a
manifestation of severe OP poisoning [6,12,16,17].
OP poisoning is a common poisoning in the warmer
regions of the world, such as South Asia, the Middle East
and Africa. So, reported fever in patients with OP poison-
ing may represent a loss of normal thermoregulation [6].
The most important limitation of this study was the
need to antidotes therapy that may affect temperature
regulation. Moreover, the treatment is individualized tongth of their hospital stay.
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ingestion of other agents in some cases which may affect
on temperature regulation. Also temperatures may also
have been affected by a patient’s location in hospital and
temperature of surrounding environment the patient in
each case.Conclusion
Hypothermia was not detected among the patients even
at the time entry. A rise in mean tympanic temperature
was found after atropine administration, although we
need more study with similar situations in tropical
countries.
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